Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Larissa A Korde"'
Autor:
Francesca Poggio, Lucia Del Mastro, Florentine S Hilbers, Saranya Chumsri, Noam F Pondé, Dominique Agbor-Tarh, Otto Metzger-Filho, Larissa A Korde, Olena Werner, Volker Moebus, Alvaro Moreno-Aspitia, Martine J Piccart
Publikováno v:
ESMO Open, Vol 5, Iss 6 (2020)
Background In HER2-positive breast cancer, time elapsed between completion of (neo)adjuvant trastuzumab and diagnosis of metastatic disease (‘trastuzumab-free interval’, TFI) is crucial to choose the optimal first-line treatment. Nevertheless, th
Externí odkaz:
https://doaj.org/article/1527dc5a1b994a6ca8d07abfc732dc49
Autor:
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna B. Sætersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong E. Lee, Janice M. Walshe, Manuel Ruíz-Borrego, Halle C.F. Moore, Christobel Saunders, Vesna Bjelic-Radisic, Snezana Susnjar, Fatima Cardoso, Karen L. Smith, Teresa Ferreiro, Karin Ribi, Kathryn Ruddy, Roswitha Kammler, Sarra El-Abed, Giuseppe Viale, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber, Olivia Pagani
Publikováno v:
New England journal of medicine, 388(18), 1645-1656. Massachussetts Medical Society
Background Prospective data on the risk of recurrence among women with hormone receptor-positive early breast cancer who temporarily discontinue endocrine therapy to attempt pregnancy are lacking. Methods We conducted a single-group trial in which we
Autor:
Ann Partridge, Olivia Pagani, Samuel M. Niman, Monica Ruggeri, Fedro Alessandro A. Peccatori, Hatem A. Azim, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna Saetersdal, Judith Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong Eon Lee, Janice Walshe, Manuel Ruiz Borrego, Halle Moore, Christobel Saunders, Vesna Bjelic-Radisic, Snezana Susnjar, Fatima Cardoso, Karen L. Smith, Teresa Ferreiro Vilarino, Karin Ribi, Kathryn Ruddy, Sarra El-Abed, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber
Publikováno v:
Cancer Research. 83:GS4-09
Background: Pregnancy after breast cancer (BC) is of substantial importance for many young women at diagnosis and during follow-up. BC treatment including standard endocrine therapy (ET) (5-10 years) may reduce ovarian reserve and the chances of subs
Autor:
Danielle B. Zakon, Coralie Poncet, Fatima Cardoso, Neven Anouk, Vicente Valero, Stefan Aebi, Kim Benstead, Oliver Bogler, Lissandra Dal Lago, Judith Fraser, Carmela Caballero, Ingrid A. Hedenfalk, Larissa A. Korde, Barbro Linderholm, John WM Martens, Lavinia P. Middleton, Melissa Murray, Catherine M. Kelly, Cecilia Nilsson, Monika Nowaczyk, Stephanie Peeters, Melanie Beauvois, Peggy Porter, Carolien P. Schroder, Isabel T. Rubio, Kathryn Ruddy, Christi van Asperen, Danielle Van Den Weyngaert, Carolien HM van Deurzen, Elise van Leeuwen-Stok, Joanna M. Vermeij, John MS Bartlett, Antonio C. Wolff, Sharon H. Giordano, W. Fraser Symmans
Publikováno v:
Cancer Research. 83:PD6-11
Introduction Breast cancer is uncommon in men. Almost all male breast cancers are hormone receptor-positive, HER2-negative, although the pathogenesis is not always attributable to an endocrine condition. A few studies have compared biological charact
Autor:
Ana F Best, Melissa Bowman, Jessica Li, Grace E Mishkin, Andrea Denicoff, Marwa Shekfeh, Larry Rubinstein, Jeremy L Warner, Brian Rini, Larissa A Korde
Publikováno v:
JNCI: Journal of the National Cancer Institute. 115:597-600
We investigated the association of SARS CoV-2 vaccination with COVID-19 severity in a longitudinal study of adult cancer patients with COVID-19. A total of 1610 patients who were within 14 days of an initial positive SARS CoV-2 test and had received
Autor:
Olga Kantor, Harold J. Burstein, Tari A. King, Steven Shak, Christy A. Russell, Armando E. Giuliano, Gabriel N. Hortobagyi, Eric P. Winer, Larissa A. Korde, Joseph A. Sparano, Elizabeth A. Mittendorf
Publikováno v:
Annals of Surgical Oncology. 29:8016-8023
Autor:
Olga Kantor, Tari A. King, Rachel A. Freedman, Erica L. Mayer, Mariana Chavez-MacGregor, Larissa A. Korde, Joseph A. Sparano, Elizabeth A. Mittendorf
Publikováno v:
JAMA Surgery.
ImportanceWhether racial and ethnic disparities in locoregional recurrence (LRR) exist among patients with similar access to care treated in randomized clinical trials is unknown.ObjectiveTo examine racial and ethnic differences in LRR among patients
Autor:
Antoni Ribas, John M. Kirkwood, Larissa A. Korde, Elad Sharon, Nageatte Ibrahim, Sama Ahsan, Scot W. Ebbinghaus, Krishna S. Gunturu, Magdalena Kovacsovics-Bankowski, Brian Gastman, Zeynep Eroglu, James Moon, Hongli Li, Douglas B. Johnson, Ragini R. Kudchadkar, Bartosz Chmielowski, Robert M. Conry, Karl D. Lewis, Pauline Funchain, Kari Kendra, Elizabeth I. Buchbinder, Justine V. Cohen, Nikhil I. Khushalani, Thach-Giao Truong, Teresa M. Petrella, Michael V. Knopp, Vernon K. Sondak, Ahmad A. Tarhini, Sapna P. Patel, Megan Othus, Kenneth F. Grossmann
Supplementary Data from Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70860ad8a591df39f1504fb8bc1ae75a
https://doi.org/10.1158/2159-8290.22541236.v1
https://doi.org/10.1158/2159-8290.22541236.v1
Autor:
Judy E. Garber, F. Lennie Wong, Sandhya Pruthi, Linda Overholser, Sofia D. Merajver, Susan A. Melin, Larissa A. Korde, Melissa M. Hudson, David Hodgson, Tara Henderson, Anne Blaes, Therese B. Bevers, Saro H. Armenian, Kathryn W. Zamora, Caroline A. Reich, Heidi Umphrey, Kandice Smith, Wendy Landier, Yanjun Chen, Lindsey Hageman, Melanie R. Palomares, Smita Bhatia
Purpose:Low-dose tamoxifen reduces breast cancer risk, but remains untested in chest-irradiated cancer survivors—a population with breast cancer risk comparable with BRCA mutation carriers. We hypothesized that low-dose tamoxifen would be safe and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::612b1477ef4dc4596da160dcf2b58fbd
https://doi.org/10.1158/1078-0432.c.6530109.v1
https://doi.org/10.1158/1078-0432.c.6530109.v1
Autor:
Razelle Kurzrock, Young Kwang Chae, Charles D. Blanke, Melissa Plets, Edward Mayerson, Robert J. Gray, Larissa A. Korde, Elad Sharon, Roisin M. Connolly, David D. Biggs, Jane M. Raymond, Olwen Hahn, Frank J. Brescia, Jordi Rodon Ahnert, Hamid R. Mirshahidi, Anne P. O'Dea, Collin T. Zimmerman, Scott A. Anderson, Mridula P. Reddy, Anna Maria V. Storniolo, Barbara J. Haley, Mary D. Chamberlin, Scott M. Schuetze, Rashmi Chugh, Kathy D. Miller, Sandip Pravin Patel, Megan Othus, Sylvia Adams
Supplemental Figure 1: CONSORT Diagram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c80dc6dec04f0090392e953ac68f745a
https://doi.org/10.1158/1078-0432.22482155
https://doi.org/10.1158/1078-0432.22482155